Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.02, marking a +2% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.44% for the day. Meanwhile, the Dow gained 0.36%, and the Nasdaq, a tech-heavy index, added 0.54%.

Heading into today, shares of the company had lost 6.54% over the past month, lagging the Medical sector’s loss of 4.11% and the S&P 500’s loss of 3.31%.

The investment community will be paying close attention to the earnings performance of Canopy Growth Corporation in its upcoming release. The company’s upcoming EPS is projected at -$0.06, signifying a 93.62% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $53.26 million, reflecting a 17.56% rise from the equivalent quarter last year.

For the full year, the Zacks Consensus Estimates are projecting earnings of -$0.36 per share and revenue of $210.58 million, which would represent changes of +87.92% and +8.94%, respectively, from the prior year.

Investors should also take note of any recent adjustments to analyst estimates for Canopy Growth Corporation. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 24.14% higher. At present, Canopy Growth Corporation boasts a Zacks Rank of #2 (Buy).

The Medical – Products industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 160, finds itself in the bottom 35% echelons of all 250+ industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.